Liver cancer: Effect of HCV clearance with direct-acting antiviral agents on HCC

Josep M Llovet¹, Augusto Villanueva²

Affiliations

¹ Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute Department of Medicine, Icahn School of Medicine at Mount Sinai, Madison Avenue 1425, New York 10029, USA; and the Liver Cancer Translational Research Laboratory, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, CIBERehd, Univesitat de Barcelona, Rosselló 153, Barcelona 08039, Spain; and the Institució Catalana de Recerca i Estudis Avançats, Passeig de Lluís Companys 23, Barcelona 08010, Spain.
² Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute and the Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Madison Avenue 1425, New York, New York 10029, USA.

PMID: 27580683
DOI: 10.1038/nrgastro.2016.140

Comment

Liver cancer: Effect of HCV clearance with direct-acting antiviral agents on HCC

Josep M Llovet et al. Nat Rev Gastroenterol Hepatol. 2016 Oct.

. 2016 Oct;13(10):561-2.

doi: 10.1038/nrgastro.2016.140. Epub 2016 Sep 1.

Authors

Josep M Llovet¹, Augusto Villanueva²

Affiliations

¹ Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute Department of Medicine, Icahn School of Medicine at Mount Sinai, Madison Avenue 1425, New York 10029, USA; and the Liver Cancer Translational Research Laboratory, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, CIBERehd, Univesitat de Barcelona, Rosselló 153, Barcelona 08039, Spain; and the Institució Catalana de Recerca i Estudis Avançats, Passeig de Lluís Companys 23, Barcelona 08010, Spain.
² Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute and the Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, Madison Avenue 1425, New York, New York 10029, USA.

PMID: 27580683
DOI: 10.1038/nrgastro.2016.140

No abstract available

PubMed Disclaimer

Comment on

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.
Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, Foschi FG, Lenzi M, Mazzella G, Verucchi G, Andreone P, Brillanti S. Conti F, et al. J Hepatol. 2016 Oct;65(4):727-733. doi: 10.1016/j.jhep.2016.06.015. Epub 2016 Jun 24. J Hepatol. 2016. PMID: 27349488
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis.
Cheung MCM, Walker AJ, Hudson BE, Verma S, McLauchlan J, Mutimer DJ, Brown A, Gelson WTH, MacDonald DC, Agarwal K, Foster GR, Irving WL; HCV Research UK. Cheung MCM, et al. J Hepatol. 2016 Oct;65(4):741-747. doi: 10.1016/j.jhep.2016.06.019. Epub 2016 Jul 5. J Hepatol. 2016. PMID: 27388925

References

1. J Hepatol. 2017 Feb;66(2):464 - PubMed
1. J Hepatol. 2016 Oct;65(4):727-33 - PubMed
1. J Hepatol. 2016 Oct;65(4):734-40 - PubMed
1. J Hepatol. 2016 Oct;65(4):859-60 - PubMed
1. J Hepatol. 2016 Oct;65(4):741-7 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Liver cancer: Effect of HCV clearance with direct-acting antiviral agents on HCC

Affiliations

Liver cancer: Effect of HCV clearance with direct-acting antiviral agents on HCC

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical